RANTES is required for ischaemia-induced angiogenesis, which may hamper RANTES-targeted anti-atherosclerotic therapy.
Westerweel
Peter E
PE
Rabelink
Ton J
TJ
Rookmaaker
Maarten B
MB
Gröne
Hermann-Josef
HJ
Verhaar
Marianne C
MC
D000818:Animals; D050197:Atherosclerosis / Q000188:drug therapy* / Q000473:pathology; D065100:CCR5 Receptor Antagonists; D018946:Chemokine CCL5 / Q000494:pharmacology / Q000502:physiology*; D006614:Hindlimb / Q000098:blood supply; D007511:Ischemia / Q000150:complications; D009389:Neovascularization, Pathologic / Q000209:etiology* / Q000517:prevention & control; D051381:Rats
D065100:CCR5 Receptor Antagonists; D018946:Chemokine CCL5; C108335:RANTES, Met-